BR9307712A - Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451) - Google Patents

Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451)

Info

Publication number
BR9307712A
BR9307712A BR9307712-2A BR9307712A BR9307712A BR 9307712 A BR9307712 A BR 9307712A BR 9307712 A BR9307712 A BR 9307712A BR 9307712 A BR9307712 A BR 9307712A
Authority
BR
Brazil
Prior art keywords
compound
sym
imi
fungal strain
sesquiterpenes
Prior art date
Application number
BR9307712-2A
Other languages
English (en)
Inventor
Didier Vincent Renno
Gerard Bernard O'beirne
Brent Raymond Copp
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of BR9307712A publication Critical patent/BR9307712A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Patente de Invenção:"SESQUITERPENO, PROCESSO PARA A PREPARAçãO DE UM COMPOSTO, COMPOSTO, COMPOSIçãO FARMACêUTICA E VETERINáRIA, E, PROCESSO PARA FERMENTAR CEPA FúNGICA X06/15/458 (IMI 354451)". Sesquiterpenos de fórmula (I) em que cada (I) (a) (b) (c) (d) em que cada um de <sym> e <sym> ;e uma ligação únida e a outra é uma ligação única e a outra é uma ligação dupla ligação; A. junto com <sym> , <sym> e os átomos de carbono ao qual é ligado forma um anel selecionado dentre; (a), (b) em que R é H ou OH, (c); e (d); é Y é uma dupla ligação ou, quando A e um anel (a) como definido acima, Y é ou uma dupla ligação ou forma, junto com os átomos de carbono aos quais eles é ligado, uma ligação epóxido <sym> obtenível a partir de uma cepa fúngica <MU>Acremonium strictum<MV> X06/15/458, e sais farmaceuticamente ou veterinariamente aceitáveis dos mesmos, são inibidores da ligação de benzodiazepina para o complexo receptor de ionóforos GABA-benzodiazepina-Cl. Estes compostos são preparados por (i) fermentação, em uma fonte de carbono, nitrogênio e sais fúngicos, da cepa fúngica X06/15/458 (IMI 354451) ou um mutante da mesma que produz os referidos sesquiterpenos, (ii) isolamento dos sesquiterpenos do meio de fermentação e (iii) se desejado, conversão do referido sesquiterpeno em um ou um sal farmaceuticamente ou veterinariamente aceitável do mesmo.
BR9307712-2A 1992-12-22 1993-12-22 Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451) BR9307712A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226724A GB9226724D0 (en) 1992-12-22 1992-12-22 Pharmaceutical compounds
PCT/GB1993/002632 WO1994014814A1 (en) 1992-12-22 1993-12-22 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor

Publications (1)

Publication Number Publication Date
BR9307712A true BR9307712A (pt) 1999-08-31

Family

ID=10727034

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307712-2A BR9307712A (pt) 1992-12-22 1993-12-22 Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451)

Country Status (23)

Country Link
US (1) US5565486A (pt)
EP (1) EP0675888A1 (pt)
JP (1) JPH08504804A (pt)
KR (1) KR950704324A (pt)
AU (1) AU677272B2 (pt)
BG (1) BG99736A (pt)
BR (1) BR9307712A (pt)
CA (1) CA2151251A1 (pt)
CZ (1) CZ284121B6 (pt)
FI (1) FI953081A0 (pt)
GB (2) GB9226724D0 (pt)
HU (1) HUT71859A (pt)
IL (1) IL108140A (pt)
MX (1) MX9400174A (pt)
NO (1) NO952483L (pt)
NZ (1) NZ258986A (pt)
PL (1) PL309628A1 (pt)
RU (1) RU95113350A (pt)
SG (1) SG67345A1 (pt)
SK (1) SK77595A3 (pt)
TW (1) TW242141B (pt)
WO (1) WO1994014814A1 (pt)
ZA (1) ZA939626B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161095A1 (en) * 2005-01-18 2007-07-12 Gurin Michael H Biomass Fuel Synthesis Methods for Increased Energy Efficiency
CA2797033C (en) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
WO2014145718A2 (en) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348284A (ja) * 1986-08-18 1988-02-29 Yamanouchi Pharmaceut Co Ltd 新抗生物質yp−02908l−aおよびその製造法
DE3850260T2 (de) * 1987-02-06 1994-09-22 Snow Brand Milk Prod Co Ltd Herstellung von 7-beta-Hydroxy-4-pregnen-3,20-dion-Derivaten.
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
JP2842613B2 (ja) * 1989-04-28 1999-01-06 塩野義製薬株式会社 フォスフォリパーゼa▲下2▼阻害物質
JPH03108490A (ja) * 1989-06-30 1991-05-08 Shionogi & Co Ltd フォスフォリパーゼa↓2阻害物質
US5130430A (en) * 1990-10-31 1992-07-14 Neurogen Corporation 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder

Also Published As

Publication number Publication date
GB2284603A (en) 1995-06-14
GB9503413D0 (en) 1995-04-12
IL108140A (en) 1997-06-10
ZA939626B (en) 1994-08-18
WO1994014814A1 (en) 1994-07-07
BG99736A (bg) 1996-04-30
EP0675888A1 (en) 1995-10-11
MX9400174A (es) 1994-07-29
JPH08504804A (ja) 1996-05-28
FI953081A (fi) 1995-06-21
AU677272B2 (en) 1997-04-17
FI953081A0 (fi) 1995-06-21
NO952483D0 (no) 1995-06-21
IL108140A0 (en) 1994-04-12
CZ284121B6 (cs) 1998-08-12
HUT71859A (en) 1996-02-28
CA2151251A1 (en) 1994-07-07
US5565486A (en) 1996-10-15
HU9501840D0 (en) 1995-08-28
GB9226724D0 (en) 1993-02-17
SG67345A1 (en) 1999-09-21
PL309628A1 (en) 1995-10-30
AU5709694A (en) 1994-07-19
SK77595A3 (en) 1995-12-06
CZ164695A3 (en) 1995-11-15
NZ258986A (en) 1996-11-26
RU95113350A (ru) 1997-06-10
KR950704324A (ko) 1995-11-17
GB2284603B (en) 1996-03-27
NO952483L (no) 1995-08-15
TW242141B (pt) 1995-03-01

Similar Documents

Publication Publication Date Title
BR0111754A (pt) Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
TW281675B (pt)
HUP0004040A1 (hu) Antimikrobiális hatású pleuromutilinszármazékok, eljárás ezek előállítására, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
AU1843297A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
YU49459B (sh) Postupak za dobijanje azacikloheksapeptida
EP1018513A3 (en) Quinolinecarboxylic acid derivatives
BR0010348A (pt) Uso de antagonistas seletivos de receptor &lt;244&gt;~ 1b~-adrenérgico para aperfeiçoamento de disfunção sexual
AU2838497A (en) Process for the preparation of substituted aryllactic acid- containing cyclodepsipeptides having 24 ring atoms
EP1437359A3 (en) Novel 3,6-Hemiketals from the Class of 9a-Azalides
CA2085258A1 (en) Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
BR9307712A (pt) Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451)
Chen et al. Biosynthesis of boromycin
DE69722202D1 (de) Dihydrobenzopyran und ähnliche verbindungen verwendbar als antientzündungsmittel
BR0109268A (pt) Método de preparação de citalopram, composto e citaplopram
US4487761A (en) Dopamine β-hydroxylase inhibitors
NAKAGAWA et al. Inhibition of platelet aggregation by medermycin and it's related isochromanequinone antibiotics
AU4478485A (en) 2-phenoxymethyl-imidazoline derivatives
IS3815A (is) Afleiður fjölhydroxyfimmhringa-efna, framleiðsla þeirra og notkun sem lyfja
KR900004939A (ko) 농화학적으로 유용한 활성 성분들의 미생물에 의한 제조 방법
NO832046L (no) Mikroorganismestammen chromobacterium violaceum, farmasoeytisk aktive forbindelser fremstilt av stammen, fremgangsmaate til fremstilling av forbindelsene og deres anvendelse som legemiddel
EP0136923B1 (en) 2-amino-1,9-dihydro-6h-purin-6-one-7-oxide, the pharmaceutically acceptable salts and a process for the production thereof
SU122846A3 (ru) Способ получени спирамицина
GB1388878A (en) Antibiotics process for their production and use in ruminant feed
ES8401966A1 (es) Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n&#39;-r) guanidinas.
Sheikh et al. Biogenesis of the N-methyl group of pyocyanine

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal